AACR news: squalamine evaluated for activity in prostate and lung cancer models April 20, 1999 No Comments
FDA grants priority review status to Alza' sNDA for Doxil in ovarian cancer April 20, 1999 No Comments
SBR-170: a new bioreductive alkylating agent selected for further evaluation April 20, 1999 No Comments
News from AACR: 9-NC does not require conversion to 9-AC to exert antitumor activity April 19, 1999 No Comments
NX-211 compared to free lurtotecan regarding pharmacokinetics, toxicity and efficacy April 19, 1999 No Comments